AB22002 - A dose-ranging study to investigate efficacy and safety of buntanetap in participants with early AD
Clinical Trial Grant
Awarded By
Annovis Bio, Inc.
Start Date
December 7, 2022
End Date
August 8, 2024
Awarded By
Annovis Bio, Inc.
Start Date
December 7, 2022
End Date
August 8, 2024